Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
Dear Editor,PD-1 is a type Ⅰ immune inhibitory transmembrane receptor of the CD28 family that modulates the activity of T cells in peripheral tissues ”1”.It is expressed in T cells,B cells,monocytes,natural killer cells and many tumor-infiltrating lymphocytes ”2”.
27
2017-02-27(万方平台首次上网日期,不代表论文的发表时间)
147-150